(Press-News.org) WASHINGTON (May 13, 2015) -- An early phase study testing an anti-PDL1 agent in combination with standard chemotherapy in the treatment of advanced non-small cell lung cancer has provided promising early results, prompting multiple phase III studies in lung cancer. The findings are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO).
In this phase 1b study, patients with untreated non-small cell lung cancer received one of three standard platinum-based chemotherapy regimens (paclitaxel/carboplatin, pemetrexed/carboplatin or nab-paclitaxel/carboplatin) with MPDL3280A, an antibody targeting PD-L1. Early results from the first 37 patients showed impressive response rates between 60-75 percent, comparing favorably to historical outcomes with chemotherapy alone, where historical response rates from randomized trials are around 30 - 35 percent. In addition, two complete responses already have been documented, with no evidence of lung cancer on CT scans.
"A complete response is not typically seen in patients with stage IV lung cancer," says the abstract's lead author, Stephen V. Liu, MD, assistant professor of medicine at Georgetown Lombardi Comprehensive Cancer Center. "And the response rates seen with MPDL3280A and chemotherapy were higher than one would expect with chemotherapy alone."
Researchers say the combination therapy was well tolerated by patients, with no unexpected toxicities. The most frequently reported adverse events were linked to use of chemotherapy, investigators report, including nausea, fatigue, and constipation. Side effects associated with MPDL3280A use included anemia, low levels of neutrophils, which can increase the risk of infection, and low platelet counts, which can increase the risk of bleeding.
The research team includes researchers from University of Colorado; Duke University Medical Center; Massachusetts General Hospital; Carolina BioOncology Institute; Dana-Farber Cancer Institute; and Yale Cancer Center.
Anti-PD-L1 and anti-PD1 antibodies are designed to enhance the activity of T-cells (immune cells), white blood cells capable of destroying cancer cells. "The body needs to tightly regulate immune function," Liu explains. "When T-cells are activated under normal conditions, they are quickly suppressed, to prevent over-activation. This suppression is controlled by the interaction of PD1 (a receptor on the immune cells) and PD-L1, the protein that binds to the PD1 receptor.
"The problem is that many tumors express PD-L1 and are able to escape T-cell immunity," Liu says. "So these drugs are designed to keep the immune signal on."
The U.S. Food and Drug Administration has approved two anti-PD1 antibodies for the treatment of refractory melanoma and one anti-PD1 antibody for the treatment of refractory squamous cell lung cancer, he says. "MPDL3280A represents an approach at targeting not PD1, but its ligand, PD-L1, which may provide some advantages. The combination with chemotherapy in the first line setting certainly deserves further study," Liu says.
INFORMATION:
Genentech funded the study. Liu serves on the advisory board for Genentech.
About Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and MedStar Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Georgetown Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute (grant #P30 CA051008), and the only one in the Washington, DC area. For more information, go to http://lombardi.georgetown.edu.
About Georgetown University Medical Center
Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award from the National Institutes of Health.
MANHATTAN, Kansas -- Our belief in pure evil influences our feelings about capital punishment, finds a Kansas State University psychology study.
Donald Saucier, associate professor of psychological sciences and 2015-2016 Coffman chair for distinguished teaching scholars, looked at how beliefs in pure evil influenced how people treated those who committed crimes. He recently completed the study with Russell Webster at St. Mary's College of Maryland.
Approximately 200 participants were given a summary of a case in which a murderer confessed to his crime. Researchers then ...
AURORA, Colo. (May 14, 2015) - More than half of all Medicaid enrollees prefer the "one-stop shop" of a hospital emergency department to receive care for conditions that could be treated effectively at a primary care clinic, according to an article by a researcher at the University of Colorado School of Medicine on the Anschutz Medical Campus.
The finding exposes a gap in the services provided to Medicaid enrollees. From a patient's perspective, going to the hospital emergency department may be less expensive because patients can avoid costs of travel and time away from ...
PHILADELPHIA - In the first-of-its-kind study since the passage of the HIV Organ Policy Equity Act (the HOPE Act), which lifted the ban on organ donations from one HIV-positive person to another, Penn Medicine researchers report on the quality of these organs and how their use might impact the country's organ shortage. The study, published online ahead of print May 14 in the American Journal of Transplantation, revealed that there are nearly 400 HIV-positive potential organ donors who could be sources of donated organs annually for HIV-positive patients waiting for organ ...
All land is not created equal. Some ecosystems do triple duty in the benefits they provide to society. Massachusetts forests, for example, filter public drinking water while also providing habitat for threatened species and storing carbon to combat climate change.
Ecologists and conservation groups single out the hardest-working ecosystems -- called "hotspots" -- for their exceptional conservation value. A new study published today in the Journal of Applied Ecology reports that the number of ecosystem hotspots has increased in Massachusetts over the past decade, with ...
In 2013, the United States government passed the HIV Organ Policy Equity (HOPE) Act, which allows research to be conducted on the safety of organ donation from deceased donors with HIV to recipients with HIV. A new study published in the American Journal of Transplantation explores the quality of these organs and how their use might impact the country's organ shortage.
In the United States, there are not enough organ donors to meet the needs of all patients who might benefit from lifesaving organ transplants. Some patients waiting for organs are infected with HIV, and ...
CHICAGO -- With the increasing demand for food with health benefits, high nutritional value food materials are attracting more attention from both consumers and food manufacturers. A new study by researchers at Wilmar (Shanghai) Biotechnology Research and Development Center Co., Ltd. in the Journal of Food Science, published by the Institute of Food Technologists (IFT), found that germinated buckwheat, an important raw material for food and functional food production, had better nutritional value than ungerminated buckwheat.
Germination is a complex process in which ...
An article publishing online today in Brain: A Journal of Neurology has found that individual differences in brain structure could help to determine the risk for future drug addiction. The study found that occasional users who subsequently increased their drug use compared with those who did not, showed brain structural differences when they started using drugs.
In the two studies, researchers, led by Dr. Benjamin Becker, scanned the brain structure of 66 participants to provide the first likely evidence showing volumes of fronto-striato-limbic regions of the brain have ...
A robotic arm that can bend, stretch and squeeze through cluttered environments has been created by a group of researchers from Italy.
Inspired by the eight arms of the octopus, the device has been specifically designed for surgical operations to enable surgeons to easily access remote, confined regions of the body and, once there, manipulate soft organs without damaging them.
It is believed the device could reduce the number of instruments, and thus entry incisions, necessary in surgical operations, with part of the arm being used to manipulate organs whilst another ...
The use of glycated haemoglobin (sugar-bound haemoglobin, or HbA1c) is now in almost universal use to assist doctors in the diagnosis of type 2 diabetes. However new research published in Diabetologia (the journal of the European Association for the Study of Diabetes) highlights how anaemia--a common condition in the general population, especially in women--can lead to a false diagnosis of diabetes based on HbA1c, when a person's blood sugar control is actually normal. The research is by Dr Emma English, University of Nottingham, UK, and colleagues.
In recent years, ...
Weak grip strength is linked with shorter survival and a greater risk of having a heart attack or stroke, according to an international study involving almost 140000 adults from 17 culturally and economically diverse countries [1].
The study, published in The Lancet, also found that grip strength is a stronger predictor of death than systolic blood pressure, and the authors suggest that it could be used as a quick, low-cost screening tool by doctors or other healthcare professionals to identify high-risk patients among people who develop major illnesses such as heart ...
